The biological significance of plasmalogens in defense against oxidative damage

Experimental Gerontology

Volumn 33, Issue 5, 1998, Pages 363-369

  Brosche, Thorolf ^a   Platt, Dieter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aging; Antioxidant; Atherosclerosis; Neuronal tissue; Peroxisomal disorders; Plasmalogens; Plasmenyl phospholipids

Indexed keywords

ANTIOXIDANT; ETHER LIPID; FATTY ACID ESTER; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PLASMALOGEN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGING; ATHEROSCLEROSIS; CELL MEMBRANE; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; SHORT SURVEY;

BOS TAURUS; MAMMALIA; SUIDAE;

EID: 0032147165     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00014-X     Document Type: Review

References (37)

1. Agamanolis D.P., Novak R.W. Rhizomelic chondrodysplasia punctata Report of a case with review of the literature and correlation with other peroxisomal disorders . Pediatr. Pathol. Lab. Med. 15:1995;503-513.
2. Batna A., Fuchs C., Spiteller G. Lipid peroxidation in presence of ebselen. Chem. Phys. Lipids. 87:1997;149-158.
3. Blank M.L., Cress E.A., Smith Z.L., Snyder F. Meats and fish consumed in the American diet contain substantial amounts of ether-linked phospholipids. J. Nutr. 122:1992;1656-1661.
4. Bräutigam C., Engelmann B., Reiss D., Reinhardt U., Thiery J., Richter W.O., Brosche T. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL-apheresis. Atherosclerosis. 119:1996;77-88.
5. Brosche T. Plasmalogen phospholipids - Facts and theses to their antioxidative qualities. Arch. Gerontol. Geriatr. 25:1997;291-296.
6. Brosche T., Kral C., Summa J.D., Platt D. Effective lovastatin therapy in elderly hypercholesterolemic patients - An antioxidative impact? Arch. Gerontol. Geriatr. 22:1996;207-221.
7. Buddecke E., Andresen G. Quantitative Bestimmung der Acetalphosphatide (Plasmalogene) in der Aorta des Menschen unter Berücksichtigung der Arteriosklerose. Hoppe-Seyler's Z. Physiol. Chem. 314:1959;38-45.
8. Dudda A., Spiteller G., Kobelt F. Lipid oxidation products in ischemic porcine heart tissue. Chem. Phys. Lipids. 82:1996;39-51.
9. Engelmann B., Streich S., Schönthier U.M., Richter W.O., Duhm J. Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. I. Increased phosphatidylcholine and reduced sphingomyelin in patients with elevated levels of triacyl-rich lipoproteins. Biochim. Biophys. Acta. 1165:1992;32-37.
10. Engelmann B., Bräutigam C., Thiery J. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins. Biochim. Biophys. Res. Commun. 204:1994;1235-1242.
11. Esterbauer H., Ramos P. Chemistry and pathophysiology of oxidation of LDL. Rev. Physiol. Biochem. Pharmacol. 127:1996;31-64.
12. Farooqui A.A., Rapoport S.I., Horrocks L.A. Membrane phospholipid alterations in Alzheimer's disease Deficiency of ethanolamine plasmalogens . Neurochem. Res. 22:1997;523-527.
13. Felde R., Spiteller G. Plasmalogen oxidation in human serum lipoproteins. Chem. Phys. Lipids. 76:1995;259-267.
14. Foglia T.A., Nungesser E., Marmer W.N. Oxidation of 1-O-(alk-1-eny)-2,3-Di-O-acylglycerols Models for plasmalogen oxidation . Lipids. 23:1988;430-435.
15. Ginsberg L., Rafique S., Xuereb J.H., Rapoport S.I., Gershfeld N.L. Disease and anatomic specifity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 698:1995;223-226.
16. Giros M., Roels F., Prats J., Ruiz M., Ribes A., Espeel M., Wanders R.J., Schutgens R.B., Pamplos T. Long survival in a case of peroxisomal biogenesis disorder with peroxisome mosaicism in the liver. Ann. NY Acad. Sci. 804:1996;747-749.
17. Harman D. Free radical theory of aging Alzheimer's disease pathogenesis . Age. 18:1995;97-119.
18. Hayashi H., Hara M. 1-Alkenyl group of ethanolamine plasmalogen derives mainly from de novo-synthesized fatty alcohol within peroxisomes, but not extraperoxisomal fatty alcohol or fatty acid. J. Biochem. Tokyo. 121:1997;978-983.
19. Heymans, H.S.A., Oorthuys, J.W.E., Nelck, G., Wanders, R.J.A., Dingemans, K.P., and Schutgens, R.B.H., Peroxisomal abnormalities in rhizomelic chondrodysplasia punctata. J. Inherit. Metab. Dis. 9(Suppl 2), 329-331, 1985.
20. Hofer G., Lichtenberg D., Kostner G.M., Hermetter A. Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins Alkenylacyl subclasses are preferred targets . Clin. Biochem. 29:1996;445-450.
21. Jansen G.A., Wanders R.J. Plasmalogens and oxidative stress Evidence against a major role of plasmalogens in protection against the superoxide anion radical . J. Inherit. Metab. Dis. 20:1997;85-94.
22. Jira W., Spiteller G. Plasmalogens and their oxidative degradation products in low and high density lipoprotein. Chem. Phys. Lipids. 79:1996;95-100.
23. Jürgens G., Fell A., Ledinski G., Chen Q., Paltauf F. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens. Chem. Phys. Lipids. 77:1995;25-31.
24. Kleinveld H.A., Demacker P.N.M., De Haan A.F.J., Stalenhoef A.F.H. Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Eur. J. Clin. Invest. 23:1993;289-295.
25. Lukacova N., Halat G., Chavko M., Marsala J. Ischemia-reperfusion injury in the spinal cord of rabbits strongly enhances lipidperoxidation and modifies phospholipid profiles. Neurochem. Res. 21:1996;869-873.
26. Lukacova N., Marsala M., Halat G., Marsala J. Neuroprotective effect of graded postischemic reoxigenation in spinal cord ischemia in the rabbit. Brain Res. Bull. 43:1997;457-465.
27. Mangold H.K., Weber N. Review: Biosynthesis and biotransformation of ether lipids. Lipids. 22:1987;789-799.
28. Morand O.H., Zoeller R.A., Raetz C.R.H. Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation. J. Biol. Chem. 263:1988;11597-11606.
29. Nagan N., Hajra A.K., Das A.K., Moser H.W., Moser A., Lazarow P., Purdue P.E., Zoeller R.A. A fibroblast cell line defective in alkyl-dihydroxyacetone phosphate synthase A novel defect in plasmalogen biosynthesis . Proc. Natl. Acad. Sci. USA. 94:1997;4475-4480.
30. Regnstrom J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility of low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339:1992;1183-1186.
31. Reiss D., Beyer K., Engelmann B. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J. 323:1997;807-814.
32. Rouser G., Yamamoto A. Curvilinear regression course of human brain lipid composition changes with age. Lipids. 3:1968;284-287.
33. Wanders R.J.A., Purvis Y.R., Heymans H.S.A., Bakkeren J.A.J.M., Parmentier G.G., Van Elderle J., Eyssen H., Van den Bosch H., Tager J.M., Schutgens R.B.H. Age-related differences in plasmalogen content of erythrocytes from patients with the cerebro-hepato-renal (Zellweger) syndrome Implications for postnatal detection of the disease . J. Inherit. Metab. Dis. 9:1986;335-342.
34. Weisser M., Spiteller G. Increase of aldehydic compounds derived from plasmalogens in the brain of aged cattle. Chem. Phys. Lipids. 82:1996;173-178.
35. Yavin R.A., Gatt S. Oxygen-dependent cleavage of the vinyl-ether linkage of plasmalogens. Eur. J. Biochem. 25:1972;437-446.
36. Zoeller R.A., Morand O.H., Raetz C.R.H. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263:1988;11590-11596.
37. Zommara M., Tachibana N., Mitsui K., Nakatani N., Sakono M., Ikeda I., Imaizumi K. Inhibitory effect of ethanolamine plasmalogen on iron- and copper-dependent lipid peroxidation. Free Radical Biol. Med. 18:1995;599-602.